However, prices are notoriously variable, and "price" can have multiple potential meanings (e.g., cost of service provision, cost plus profit, charges, or expected reimbursement, among others). To illustrate, consider three general sources that might be considered for displaying the "price" of certain tests (Table) . In this example, potential displayed amounts vary as much as tenfold.
Which "price" is right? Implementing price displays requires more than knowing only whether doing so effectively decreases expenditures. In this Viewpoint we suggest that several ethical values should be considered to guide the design and implementation of providing price displays to physicians. While recognizing its sometimes ambiguous use in this context, we refer simply to "price" throughout; our goal is to offer ethical clarity on choosing an amount to display.
Price Displays in Practice
In an ideal world, physician price displays may represent an attractive way to help control costs. Providing physicians with prices of interventions, tests, and treatments they order could facilitate physicians' increasingly recognized obligation to provide cost-effective, high-value care. 5 Physicians already consider prices, but often with insufficient knowledge. 6 Integrating price displays into computerized physician order entry (CPOE) at the point-ofcare could help remedy this knowledge gap. Price displays also could potentially lead to reduced use of marginally beneficial interventions, thereby helping to prevent overtreatment, harms to patients from adverse events, or unnecessary costs. This information could facilitate physician-patient shared decision-making about treatment options and their potential effects on patients' health and non-health related values, including out-of-pocket costs (i.e., the dollar amount they will ultimately pay). Also, because physicians retain control over the ordering decision, price displays should neither infringe physicians' professional autonomy nor impede fiduciary obligations to their patients.
The real world is far from ideal. Although price displays may preferentially decrease orders for harmful or marginally beneficial care, they could risk reducing beneficial care as well. In addition, although prices might be discussed with outpatients, such discussions may be less feasible or appropriate in settings (e.g., certain inpatient units, intensive care units, or emergency departments) where patients are potentially severely ill, the volume of orders is high, and patients' out-of-pocket responsibility is uncertain. In these acute care settings price displays operate at the physician level, encouraging clinicians to "think twice" before ordering daily labs, X-rays, etc., on patients' behalf. Nevertheless, several ethical values could guide decisions about which price to display and how.
Transparency
Independent of the price chosen, transparency requires informing physicians of the source of the price (eg, list price, Medicare fee). At the very least, reference to the source of the price should be shown alongside the price display. Ideally, health care organizations should also engage physicians in decisions about implementing price displays and other costcontainment initiatives.
Informing Patients
Because patient care could be affected by price displays, patients will be sensitive to the use of prices in clinical decision-making. Protecting patient autonomy requires informing patients that price displays are being used. This should ideally occur through physicianpatient shared decision-making, in which the price of a service and its potential influence on a patient's out-of-pocket costs are discussed in conjunction with relevant clinical information, such as potential benefits and risks. Patients may be most concerned about these out-of-pocket costs; it may be desirable to program CPOE systems to display these out-of-pocket costs (analogous to current capabilities displaying patients' prescription drug formularies). Even patients not made aware of the use of price displays through shared decision-making (e.g., due to illness acuity) should be aware that such displays are in use generally. This could be accomplished via notification upon hospital admission, general notices within clinical settings, and/or other methods, perhaps as part of broader patient engagement efforts.
Protecting Well-being
If physicians order ever fewer tests as the amount of the displayed price increases, displaying higher prices creates a greater risk of patients not receiving beneficial services. For instance, a physician may order fewer daily chest X-rays when shown a price of $385 as compared to a price of $29. Protecting patients' well-being and physicians' obligations of beneficence may require an upper limit on the amount displayed. Although health care organizations might consider displaying the highest possible price to reduce utilization, physicians and patients could perceive this as dishonest; this may reduce the long-term effectiveness of price displays. For example, list price may be easily programmable into an organization's CPOE; however, because this price is systematically and substantially higher than most other options (and is rarely, if ever, actually paid), displaying this price could create serious concerns about its use to change ordering practices.
Ensuring Fair Treatment
Fairness mandates that price displays should not systematically disadvantage certain patient groups. This is a concern for options that would display different amounts for different patients. Consider an organization that chooses to display the amount expected to be reimbursed from each patient or from his/her insurance company. These amounts will generally be lower than list prices, decreasing the risk of reducing potentially beneficial care, but will vary between patients. If displaying these prices affects ordering, certain patients could be unfairly treated. For example, if a physician ordering blood counts is shown amounts of $11 for a Medicare patient, $23 for a privately insured patient, and $142 for an uninsured or self-pay patient, the uninsured patient may be least likely to receive the test, and this would violate fairness.
Variable pricing is particularly concerning when shared decision-making is more difficult (e.g., the ICU). In acute care settings, where discussions with patients about prices may be less feasible or appropriate, implementing prices displays may require special attention to fairness. Here a case might be made for displaying a standard reference price, such as the Medicare fee, for all patients. These amounts are publicly available and explicitly designed to represent true costs incurred by the hospital. 7 Displaying the same amount for all patients could help ensure they are treated fairly.
Conclusion
Providing physicians with price displays that are transparent, inform patients, protect wellbeing and ensure fairness may be effective in helping to contain costs. A single "price" may not suit all clinical circumstances. Unanswered questions remain, such as whether displaying prices for all orders will cause physicians to ignore them eventually (limiting effectiveness) and should be limited to only specific orders (e.g., those ordered frequently or associated with high cost or marginal benefit). Future research should explore how physicians use different displayed prices across diverse clinical settings, including their influence on core ethical values.
